2026 жылында Түркияда көз рагын емдеуге бойынша ең жақсы бағалар мен клиникалар туралы біліңіз

Turkey provides advanced treatment for various eye cancers, including adult intraocular melanoma, childhood retinoblastoma, and eyelid tumors. Specialized centers use high-tech globe-salvaging techniques like Ruthenium-106 plaque brachytherapy, proton therapy, and transpupillary thermotherapy to destroy malignant cells while preserving the patients vision and the eyeball.

• Plaque brachytherapy: Localized radiation using Ruthenium-106 or Iodine-125 discs attached to the eye.
• Globe-salvaging surgery: Precise techniques like iridectomy or local excision to remove tumors safely.
• Advanced optics: Laser photocoagulation and transpupillary thermotherapy target deep intraocular tumors with heat.
• Systemic therapy: Specialized clinics offer intravitreal injections and topical chemotherapy for surface cancers.

Bookimed Expert Insight: Bookimed data shows a strong preference for Istanbul-based specialists like Dr. Muhammet Derda Ozer, who has performed over 25,000 surgeries. Clinics such as Anadolu Medical Center maintain a competitive edge through their Johns Hopkins affiliation, providing US-standard oncology protocols at 76% lower costs. This combination of high surgical volume and international academic partnerships makes Turkey a global leader in ocular oncology.

Patient Consensus: Patients value the focus on saving the eye rather than just removing the tumor. Many share relief at maintaining sight through specialized plaque radiotherapy when other centers recommended full removal.

Ocular cancer surgery in Turkey is highly safe at JCI-accredited oncology centers, achieving tumor control success rates of 95% to 98%. Most procedures utilize advanced plaque brachytherapy or tumor excision. High-volume facilities in Istanbul maintain safety standards equivalent to elite US and European hospitals.

• Success rates: Specialized brachytherapy for uveal melanoma achieves 95% to 98% local tumor control.
• Accreditation standards: Top hospitals hold JCI and ISO certifications, ensuring rigorous international safety protocols.
• Vision risks: Partial or complete vision loss possible based on tumor proximity to the optic nerve.
• Surgical complications: Potential risks include vitreous hemorrhage, retinal detachment, infection, or permanent appearance changes.

Bookimed Expert Insight: Data shows that choosing an integrated oncology center like Anadolu Medical Center, which is affiliated with Johns Hopkins, provides a safety advantage. These centers combine ophthalmology with radiation oncology expertise. This multidisciplinary approach is essential for rare ocular tumors where individual surgeon volume exceeds 25,000 procedures.

Patient Consensus: Patients emphasize planning for significant vision changes and suggest stocking low-vision aids before traveling. Many recommend prioritizing high-volume oncology departments over general eye clinics to ensure better long-term monitoring.

Select a Turkish ocular-oncologist with a Fellow of the European Board of Ophthalmology (FEBO) designation and International Council of Ophthalmology (FICO) advanced certification. Prioritize surgeons with fellowships from premier global centers like the Wills Eye Institute and membership in the Turkish Ophthalmological Association.

• International board certification: Seek the European Board of Ophthalmology Diploma (EBOD) or FICO advanced credentials.
• Specialized fellowship training: Prioritize surgeons with ocular oncology fellowships from renowned US or European institutes.
• Clinical experience: Choose specialists like Associate Professor Muhammet Derda Ozer, who has performed 25,000 procedures.
• Hospital accreditation: Ensure the facility holds Joint Commission International (JCI) or OECI cancer center accreditation.

Bookimed Expert Insight: Top-tier Turkish ocular oncologists often hold dual fellowships. For instance, Prof. Ali Riza Cenk Celebi at Istinye University Liv Hospital combined rigorous Turkish training with a Harvard Medical School fellowship. This bridges local expertise with high-tech Western protocols for complex orbitotomy or enucleation cases.

Patient Consensus: Experienced patients recommend verifying a surgeon's international training over local Turkish boards alone. They suggest cross-referencing PubMed publications to confirm the doctor regularly treats specific eye cancers like melanoma or retinoblastoma.

Visual outcomes after plaque brachytherapy typically involve a gradual decline in acuity over 2 to 5 years. While the procedure successfully preserves the eye in most cases, radiation-induced side effects like retinopathy or cataracts often impact long-term vision depending on tumor size and location.

• Success rates: Approximately 72% of patients maintain vision of 20/200 or better after 5 years.
• Tumor proximity: Vision is better preserved if the tumor is 5mm from the fovea.
• Radiation complications: Cataracts affect 68% of patients within 5 years but are treatable with surgery.
• Long-term outlook: Roughly 37% of patients maintain useful vision 10 years after their radiation treatment.

Bookimed Expert Insight: Data from top Istanbul centers like Anadolu Medical Center shows managing vision starts 6 months post-plaque. Using anti-VEGF injections early can significantly limit radiation retinopathy. Surgeons like Assoc Prof Dr. Muhammet Derda Ozer emphasize that tumor height matters as much as location for long-term clarity.

Patient Consensus: Many patients retain functional vision for the first 2 years but note increased light sensitivity. Frequent Amsler grid tests and tear substitutes are essential for managing daily visual changes during recovery.

Ocular cancer treatment in Turkey typically requires a stay of 1 to 4 weeks depending on the specific procedure. Brachytherapy patients usually remain for 6 to 10 days for plaque monitoring, while external radiation therapy may extend stays to 7 weeks for multiple sessions.

• Plaque brachytherapy: Patients stay 10 days including pre-op assessment, surgery, and 5-day radioactive plaque monitoring.
• Surgical enucleation: Surgeons typically require 7 to 10 days in-country for essential post-operative suture checks.
• External radiation: Outpatient protocols often necessitate 3 to 7 weeks depending on the session count.
• Long-term follow-up: Initial monitoring occurs every 3 to 6 months for the first 2 to 5 years.

Bookimed Expert Insight: High-volume centers like Dunyagoz Eye Hospital, which treats 66,000 patients annually, often provide international patient certificates that simplify medical visa extensions. Choosing a JCI-accredited clinic like Associate Professor M. Derda Ozer’s facility ensures standardized follow-up protocols that many patients transition to via telehealth after the first 14 days.

Patient Consensus: Patients recommend planning for at least 3 weeks to account for potential recovery delays. Most suggest bringing a cooling eye mask and securing the surgeon's WhatsApp for immediate post-discharge communication.

Most patients achieve a natural, symmetric appearance using custom prosthetic lenses or scleral shells after treatment in Turkey. Specialized ocularists match your healthy eye color and pattern using hand-painted or digital techniques, making the prosthetic typically indistinguishable to an observer once fully healed.

• Prosthetic eligibility: Suitable for corneal scarring, iris damage, or post-enucleation surgery cases.
• Healing timeline: Patients must wait 3 to 12 months for complete cosmetic stabilization.
• Custom fitting: Requires 3 to 6 sessions over 6 months for optimal comfort.
• Stability options: Scleral shells provide a smooth surface if the eye shape is irregular.

Bookimed Expert Insight: While many think of prosthetics only after eye removal, Turkish specialists like Dr. Ali Riza Cenk Celebi at Istinye University Liv Hospital use advanced contact lens fitting to restore appearance even when the globe is preserved. Our data shows that high-volume centers performing 20,000+ procedures annually often have on-site ocularists. This integration ensures the prosthetic is designed while the surgeon manages the final stages of healing.

Patient Consensus: Patients report that providing high-quality photos of their healthy eye is essential for precise color matching. Many recommend practicing insertion techniques early, noting that custom-painted lenses easily pass as natural at a distance.

Istanbul, Ankara, and Antalya are the primary Turkish cities offering accredited ocular-oncology programs alongside comprehensive airport assistance. These hubs feature Joint Commission International (JCI) accredited facilities like Anadolu Medical Center and Dunyagoz, providing specialized treatments such as plaque brachytherapy and intra-arterial chemotherapy for pediatric and adult patients.

• Istanbul facilities: Dunyagoz Etiler and Anadolu Medical Center offer advanced ocular oncology and JCI-accredited care.
• Ankara expertise: Hacettepe University and Acibadem Ankara provide high-level oncology services for complex eye cancers.
• Antalya specialists: Medical Park Antalya features dedicated oncology units and experienced surgeons for orbital procedures.
• Airport assistance: Istanbul (IST) and Antalya (AYT) airports provide dedicated mobility services and tactile paths.

Bookimed Expert Insight: While many clinics claim oncology expertise, patient data shows Istanbul remains the superior choice for ocular-specific cases. Surgeons like Dr. Muhammet Derda Ozer have performed over 25,000 surgeries, reflecting a level of specialized experience rarely found in smaller regional hubs. Choosing Istanbul-based clinics often ensures access to both JCI-accredited safety and high-volume surgical expertise.

Patient Consensus: Patients recommend verifying a surgeon's specific ocular-oncology case history through reviews rather than relying on general program labels. Coordinating airport pickups through hospital packages is frequently cited as a way to reduce travel stress by 50%.